Stock MarketIs Kontoor Brands (KTB) Turning Helly Hansen Into Its Core North America Growth Engine?4 hours ago
Stock MarketEastGroup Properties (EGP) Lifts Its Dividend, Is The Stock Trading At A Discount?11 hours ago
Stock MarketIs Now a Better Time to Invest in the S&P 500 or Entire Stock Market?2 months agoIn almost every scenario, the everyday investor is better off with a diversified portfolio and letting time do the work....
Stock MarketBank of America gives stock market investors a summer reality check2 months agoInvestors spent much of 2026 treating virtually every stock market wobble as a chance to pounce. Bank of America is...
Stock MarketBorrowed money fueling US stock rally is getting more expensive | WTVB | 1590 AM · 95.5 FM2 months agoBy Karen BrettellNEW YORK, June 29 (Reuters) – The borrowed money helping to fuel the U.S. stock rally is getting...
Stock MarketThis Is the Only Stock in the S&P 500 That’s Been a Hotter Buy Than Micron Technology This Year2 months agoAs of the end of last week, shares of Micron Technology (MU 0.66%) were up close to 300% since the...
Stock Market1 Momentum Stock to Target This Week and 2 Facing Challenges2 months agoThe stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals...
Stock MarketWhy Is The Market Pricing So Much Chaos Into Microsoft Stock?2 months agoA photo taken on May 7, 2026 shows the letters AI for Artificial Intelligence on a laptop screen (top) next...
Stock MarketMarkets Brief: Which Utilities Stocks Are the Best Data Center Plays?2 months agoStocks hit a bit of an air pocket over the past week, but the turbulence was short-lived. US equities are...
Stock MarketDecoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing2 months agoHOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "Decoy"), a biotechnology company pioneering Designable...
Stock MarketCuris Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split2 months agoEleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company reaffirms guidance for dosing of initial...
Stock MarketThis COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date2 months agoModerna (NASDAQ: MRNA) shares closed up 12% on Friday, June 26, extending a run that has pushed the stock 125.51%...